Arvinas Inc. logo

Arvinas Inc.

Sector: 
Healthcare
   

Industry: 
Biotechnology

42.58
 
USD
  
0.49
  
(1.16%)
Optionable: Yes  Market Cap: 2,269 M  90-day average vol: 492,003

Previous close: 42.09  Open: 41.82  Bid: 60.25  Ask: 60.25
52 week range    
34.90   
   108.47
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Tuesday 5th July 2022
41
MarketXLS Rank marketxls
60
Value marketxls
15
Technical marketxls
50
Quality marketxls

Search for a stock
Are you?
twitterstocktwits
Chart
Financials

ARVN Income Statement

Annual

Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues7 M8 M14 M43 M22 M47 M
Cost of sales-436329-347395-706000-2 M-4 M-6 M
Gross operating profit7 M8 M14 M43 M22 M47 M
Selling Gen & administrative expense3 M4 M13 M27 M38 M62 M
Research & development expense20 M29 M45 M67 M108 M180 M
Operating income-16 M-25 M-44 M-52 M-125 M-195 M
floaterest income000000
floaterest expense000000
Other income net2 M560030-91049-23 M2 M3 M
Pre-tax Income (EBT)-14 M-24 M-41 M-70 M-119 M-191 M
Income taxes-8740800000
Net income from total operations-14 M-24 M-41 M-70 M-119 M-191 M
Minority floaterest000000
Total net income-14 M-24 M-41 M-70 M-119 M-191 M
Preferred dividendsN/A-5 M-86 MN/AN/AN/A
Net income available for common-14 M-24 M-41 M-70 M-119 M-191 M
Depreciation4363293473957060002 M4 M6 M
Amortization000000
Operating income before depreciation (EBITDA)-14 M-24 M-41 M-68 M-115 M-185 M
Total Income available for floaterest expense (EBIT)000000
Basic EPS total-0.69-1.38-25.45-2.13-3.02-3.82
Diluted EPS total-0.69-1.38-25.45-2.13-3.02-3.82
Top MarketXLS Rank stocks

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!